Decode Research Team
Semaglutide's safety profile in animal studies is established through acute, subacute, and chronic toxicology studies. Key endpoints include body weight, food consumption, clinical observations, organ weight, histopathology, and comprehensive laboratory panels. The NOAEL (no-observed-adverse-effect level) from these studies informs safe starting doses for subsequent research. Published toxicology summaries for Semaglutide in peer-reviewed literature should be consulted when designing research protocols.
⚠️ Please note: All peptides offered by Decode Peptides are strictly for research purposes only and are not intended for human consumption, medical treatment, or veterinary use. Always consult a licensed healthcare professional before making any health-related decisions.